Ontology highlight
ABSTRACT:
SUBMITTER: Bear HD
PROVIDER: S-EPMC5821429 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
Bear Harry D HD Tang Gong G Rastogi Priya P Geyer Charles E CE Zoon Christine K CK Kidwell Kelley M KM Robidoux André A Baez-Diaz Luis L Brufsky Adam M AM Mehta Rita S RS Fehrenbacher Louis L Young James A JA Senecal Francis M FM Gaur Rakesh R Margolese Richard G RG Adams Paul T PT Gross Howard M HM Costantino Joseph P JP Paik Soonmyung S Swain Sandra M SM Mamounas Eleftherios P EP Wolmark Norman N
Annals of surgical oncology 20161118 7
<h4>Background</h4>NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev.<h4>Methods</h4>A total of 1206 women with HER2-negative operable breast cancer were randomly assigned to receive one of three different docetaxel-plus-anthracycline-based regimens, without or with bev (15 mg/kg every 3 weeks) for ...[more]